Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667123 | PMC |
| http://dx.doi.org/10.1016/j.hrcr.2023.09.001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Insertable cardiac monitor malfunction secondary to alexandrite laser procedure.
JAAD Case Rep
July 2024
Department of Dermatology, University of California, Irvine, California.
Malfunction of an insertable cardiac monitor with a long-sensing vector attributed to a mechanical failure: A case report.
HeartRhythm Case Rep
November 2023
Department of Cardiovascular Medicine, Sendai City Hospital, Miyagi, Japan.
Role of insertable cardiac monitors in anticoagulation therapy in patients with atrial fibrillation at high risk of bleeding.
Europace
June 2016
Cardiovascular and Heart Rhythm Consultants, 30 West 60th Street, Suite 1U, New York, NY 10023, USA
Aims: We aimed to ascertain whether an insertable cardiac monitor (ICM)-guided rhythm-control strategy and assessment of atrial fibrillation (AF) burden may allow safe withdrawal and obviate long-term use of oral anticoagulants (OACs) in AF patients at high bleeding risk.
Methods And Results: We implanted ICMs in 70 patients with AF with high risk of stroke (CHADS2 ≥2, CHA2DS2-VASc score ≥2) and bleeding (HAS-BLED score ≥3) after restoration of normal sinus rhythm (NSR) for continuous rhythm monitoring and optimization of antiarrhythmic drugs (AADs) when necessary. Patients were categorized into: (i) Group A (NSR/low AF burden, <1%), (ii) Group B (moderate/variable AF burden), and (iii) Group C (high AF burden, always AF).